GuruFocus
14 Jul 2026, 16:00 UTC · 10w ago
Verdict
Headline takes no side. We score NXTC −0.40 across one claim — moderately bearish.
−0.40moderately bearish
More negative than 70% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
Ademi LLP has launched an investigation into whether NextCure, Inc. (NAS:NXTC) is obtaining a fair price for its public shareholders.
More negative than 77% of claims this week
Which stocks this story touches
Scored by the NIS engine · methodology.
Search tags
More negative than 70% of ticker scores this week
The company is under investigation by a law firm to determine if public shareholders are receiving a fair price.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+133.0%
Price is moving against the score
$5.08 vs $2.18 close before publication (Jul 13) · not market-adjusted
NXTC chart →